Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The investigators propose a 3-treatment, placebo-controlled, double-dummy, double-blinded,
randomized, crossover study in which single doses of placebo, will be compared to Fluticasone
propionate (Flovent Diskus) 250 mcg and budesonide 400 mcg administered after allergen
challenge, at cessation of the early allergic reaction (at 20% fall in FEV1 from
post-allergen peak)